Pharmacological perspectives of mistletoe therapy;Zukunft der misteltherapie aus pharmakologischer sicht

Forschende Komplementarmedizin und Klassische Naturheilkunde

Volumn 6, Issue 4, 1999, Pages 186-194

  Hajto, T ^a,b   Hostanska, K ^a   Saller, R ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b NONE   (Hungary)

Author keywords

Apoptosis; Immunomodulation; Lectins; Viscum album

Indexed keywords

CD34 ANTIGEN; CYTOKINE; DIGOXIGENIN; DNA; HEMOPOIETIC GROWTH FACTOR; INTERLEUKIN 12; INTERLEUKIN 2; PROPIDIUM IODIDE; RIBOSOME INACTIVATING PROTEIN;

APOPTOSIS; DOSE RESPONSE; FLOW CYTOMETRY; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; NONHUMAN; PLANT; REVIEW; VISCUM ALBUM;

BONE MARROW CELLS; CELLS, CULTURED; COMPLEMENTARY THERAPIES; DNA DAMAGE; HUMANS; LECTINS; LYMPHOCYTES; MISTLETOE; PHYTOTHERAPY; PLANT LECTINS; PLANT PREPARATIONS; PLANT PROTEINS; PLANTS, MEDICINAL; TOXINS, BIOLOGICAL;

EID: 0032887911     PISSN: 14247364     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (84)

1. Hajto T, Hostanska K, Gabius H-J: Modulatory potency of the β-galactoside-specific lectin from mistletoe extract (Iscador) on the host defense system in vivo in rabbits and patients. Cancer Res 1989;49:4803-4808.
2. Samuelsson G, Pettersson B: Separation of viscotoxins from the European mistletoe Viscum album L. (Loranthaceae) by chromatography on sulfoethyl sephadex. Acta Chem Scand 1970; 24:27751-27756.
3. Urech K, Schaller G, Ziska P, Giannattasio M: Comparative study on the cytotoxic effect of viscotoxin and mistletoe lectin on tumor cells in culture. Phytother Res 1995;9:49-55.
4. Müller EA, Anderer FA: A Viscum album oligosaccharide activating human natural cytotoxicity is an interferon-gamma inducer. Cancer Immunol Immunother 1990;32:221-227.
5. Sakurai A, Okumara Y: Chemical studies on the mistletoe. The structure of Taxillusin, a new flavoinoid glycoside isolation from Taxillus kaempferi. Bull Chem Soc Jpn 1983;56:542-544.
6. Becker H, Exner J: Vergleichende Untersuchungen von Misteln verschiedener Wirtsbäume an Hand der Flavonoide und Phenylcarbonsäuren. Z Pflanzenphysiol 1980;97:417-428.
7. Scheffler A, Musielski H, Scherr R: Synergismus zwischen Lektinen und Vesikeln in Viscum album L. Dtsch Z Onkol 1995;27:72-75.
8. Vester F, Mai W: Zur Kenntnis der Inhaltsstoffe von Viscum album. Freie Aminosäuren. Hoppe-Seyler's Z Physiol Chem 1960;322:273-277.
9. Sharon N: Carbohydrates as recognition determinants in phagocytosis and in lectin-mediated killing of target cells. Biol Cell 1984;51:239-246.
10. Ziska P, Franz H: Determination of lectin contents in commercial mistletoe preparations for cancer therapy using the ELISA technique; in Bog Hansen TC, Breborowicz J (eds): Lectins. Berlin, Walter de Gruyter, 1985, vol IV, pp 473-480.
11. Dietrich JB, Ribereau-Gayon G, Jung ML, Franz H, Beck JP, Anton R: Identity of the N-terminal sequences of the three A chains of mistletoe (Viscum album L.) lectins: Homology with ricin-like plant toxins and single-chain ribosome-inhibiting proteins. Anticancer Drugs. 1992;3:507-511.
12. Olsnes S, Stirpe F, Sandvig K, Pihl A: Isolation and characterization of viscumin, a toxic lectin from Viscum album L. (mistletoe). J Biol Chem 1982;257:13263-13270.
13. Holtskog R, Sandvig K, Olsnes S: Characterization of a toxic lectin in Iscador, a mistletoe preparation with alleged cancerostatic properties. Oncology 1988;45:172-179.
14. Franz H: Mistletoe lectins and their A and B chains. Oncology 1986;43:23-34.
15. Samtleben R, Kiefer M, Luther P: Characterization of the different lectins from Viscum album (mistletoe) and their structural relationship with agglutinins from Abrus precatorius and Ricinus communis; in Bog Hansen TC, Breborowicz J (eds): Lectins. Berlin, Walter de Gruyter, 1985, vol IV, pp 617-626.
16. Bushueva TL, Tonevitsky AG: Similarity of protein conformation at low pH and high temperature observed for B-chains of two plant toxins: ricin and mistletoe lectin I. FEB 1988;229:119-122.
17. Luther P, Uhlenbruck G, Reutgen H, Samtleben R, Sehrt I, Ribereau-Gayon G: Are lectins of Viscum album interesting tools in lung diseases? A review of recent results. Z Erkr Atmungsorgane 1986;166:247-256.
18. Lee RT, Gabius H-J, Lee YC: The sugar-combining area of the galactose-specific toxic lectin of mistletoe extends beyond the terminal sugar residue: Comparison with homologous toxic lectin, ricin. Carbohydr Res 1994;254:269-276.
19. Endo Y, Tsurugi K, Franz H: The site of action of the A-chain of mistletoe lectin I on eukaryotic ribosomes. The RNA N-glycosidase activity of the protein. FEBS Lett 1988;231:378-380.
20. Sandvig K, Olsnes S: Entry of the toxic proteins abrin, modeccin ricin and diphtheria toxin into cell. II. Effect of pH, metabolic inhibitors, and ionophores and evidence for toxin penetration from endocytotic vesicles. J Biol Chem 1982; 257:7504-7513.
21. Wiedlocha A, Sandvig K, Walzel H, Radzikowsky C, Olsnes S: Internalization and action of an immunotoxin containing mistletoe lectin A-chain. Cancer Res 1991;51:916-920.
22. Stirpe F, Barbieri L, Batelli MG, Soria M, Lappi - DA: Ribosome-inactivating proteins from plants: Present status and future prospects. Biotechnology 1992;10:405-412.
23. Soler MH, Stoeva S, Schwamborn C, Wilhelm S, Stiefel T, Voelter W: Complete amino acid sequence of the A chain of mistletoe lectin 1. FEBS Lett 1996;399:153-157.
24. Soler MH, Stoeva S, Voelter W: Complete fluid acid sequence of the B chain of mistletoe lectin I. Biochem Biophys Res Commun 1998;246:596-601.
25. Zinke H, Eck J, Langer M, Möckel B, Baur A, Lentzen H: Molecular cloning of the Viscum album L. (mistletoe) gene for ML-1 and characterization of the recombinant protein. Phytomedicine 1996;3(suppl 1):25.
26. Hostanska K, Hajto T, Fischer J, Lentzen H, Mengs U, Weber K, Saller R: Selective modulation of phosphatidylserine expression on various subpopulations of human peripheral blood lymphocytes by a plant lectin, Viscum album agglutinin VAA-I and its recombinant form (rVAA) in vitro. Cancer Detect Prev 1998;22(supp 1):89.
27. Hajto T, Hostanska K, Weber K, Zinke H, Fischer J, Mengs U, Lentzen H, Saller R: Effect of a recombinant lectin, Viscum album agglutinin (rVAA) on secretion of interleukin-12 in cultured human peripheral blood mononuclear cells and on NK cell-mediated cytotoxicity of rat splenocytes in vitro and in vivo. Nat Immun 1998;16:34-46.
28. Franz H: Viscaceae lectins; in: Franz H (ed): Advances in Lectin Research. Berlin, VEB Verlag Volk und Gesundheit, 1989, vol 2, pp 25-59.
29. Josimovic IB: Zur Frage der krebshemmenden Wirkung der Aminosäuren aus Viscum album (Iscador®): Arginin und Zellstoffwechsel. Krebsgeschehen 1979;1:13-17.
30. Granger DL, Hibbs JL, Perfect JR, Durack DT: Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages. J Clin Invest 1988;81:1129-1136.
31. Robak J, Gryglewski RJ: Bioactivity of flavonoids. Pol J Pharmacol 1996;48:555-564.
32. Scheffler A, Richter C, Beffert M, Errenst M, Scheer R: Differenzierung der Mistelinhaltsstoffe nach Zeit und Ort; in Scheer R, Becker H, Berg PA (Hrsg): Grundlagen der Misteltherapie. Stuttgart, Hippokrates, 1996, pp 49-76.
33. Scheffler A, Musielski H, Scheer R: Synergismus zwischen Lektinen und Vesikeln von Viscum album L. Dtsch Z Onkol 1995;27:72-75.
34. Jordan E: Chemische und immunologische Untersuchungen von Polysacchariden und anderen hochmolekularen Inhaltsstoffen aus Viscum (L). Dissertation, Universität München, 1985.
35. Janssen O, Scheffler A, Kabelitz D: In vitro effects of mistletoe extracts and mistletoe lectins. Cytotoxicity towards tumor cells due to the induction of programmed cell death (apoptosis). Drug Res 1993;43:1221-1227.
36. Büssing A, Suzart K, Bergmann J, Pfüller U, Schietzel M, Schweizer K: Induction of apoptosis in human lymphocytes treated with Viscum album L. is mediated by mistletoe lectins. Cancer Lett 1996;99:59-72.
37. Hajto T, Hostanska K, Frei K, Rordorf C, Gabius H-J: Increased secretion of tumor necrosis factor a, interleukin 1, and interleukin 6 by human mononuclear cells exposed to β-galactoside-specific lectin from clinically applied mistletoe extract. Cancer Res 1990;50:3322-3326.
38. Hostanska K, Hajto T, Spagnoli G, Fischer J, Lentzen H, Herrmann R: A plant lectin derived from Viscum album induces cytokine gene expression and protein production in cultures of human peripheral blood mononuclear cells. Nat Immun 1995;14:295-304.
39. Hostanska K, Hajto T, Weber K, Fischer J, Lentzen H, Sütterlin B, Saller R: A natural immunity activating plant lectin, Viscum album agglutinin-I (VAA-I) induces apoptosis in human lymphocytes, monocytes, monocytic THP-1 cells and murine thymocytes. Nat Immun 1996-97;15:295-311.
40. 2+]i, and induces cell death. Naunyn Schmiedebergs Arch Pharmacol 1997;355:190-197.
41. Kim M, Rao MV, Tweardy DJ, Prakash M, Galili U, Gorelik E: Lectin-induced apoptosis of tumor cells. Glycobiology 1993;3:447-453.
42. Männel DN, Becker H, Gundt A, Kist A, Franz H: Induction of tumor necrosis factor expression by a lectin from Viscum album. Cancer Immunol Immunother 1991;33:177-182.
43. Ribereau-Gayon G, Dumont S, Müller C, Jung ML, Poindron P, Anton R: Mistletoe lectins I, II and III induce the production of cytokines by cultured human monocytes. Cancer Lett 1996;109:33-38.
44. Stein G, Henn W, von Laue H, Berg P: Modulation of the cellular and humoral immune responses of tumor patients by mistletoe therapy. Eur J Med Res 1998;3:194-202.
45. Stein GM, Meink H, Durst J, Berg PA: Release of cytokines by a fermented lectin-1 (ML-1) free mistletoe extract reflects differences in the reactivity of PBMC in healthy and allergic individuals and tumor patients. Eur J Clin Pharmacol 1996; 51:247-252.
46. Walzel H, Bremer H, Gabius H-J: Lectin-induced alterations in the level of phospholipids, inositol phosphates, and phosphoproteins; in Gabius H-J, Gabius S (eds): Lectins and Glycobiology. Berlin, Springer, 1993, pp 357-361.
47. Joller PW, Menrad JM, Schwarz T, Pfüller U, Parnham MJ, Weyhenmeyer R, Lentzen H: Stimulation of cytokine production via a special standardized mistletoe preparation in an in vitro human skin bioassay. Drug Res 1996;46:649-653.
48. Manetti R, Parronchi P, Guidizi MG, Piccinni MP, Maggi E, Trinchieri G, Romagnani S: Natural killer cell stimulating factor (IL-12) induces T helper type (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 1993;177:1199-1204.
49. Huang M, Stolina M, Sharma S, Mao JT, Zhu L, Miller PW, Wollman J, Herschman H, Dubinett SM: Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: Up-regulation of interleukin 10 and down-regulation of interleukin 12 production. Cancer Res 1998;58:1208-1216.
50. Metzner G, Franz H, Kindt A, Fahlbusch B, Süss J: The in vitro activity of lectin from mistletoe (ML-I) and its isolated A and B chains on functions of macrophages and polymorphonuclear cells. Immunobiology 1985;169:461-471.
51. Timoshenko AV, Gabius HJ: Efficient induction of superoxide release from human neutrophils by the galactoside-specific lectin from Viscum album. Biol Chem Hoppe Seyler 1993;374:237-243.
52. Wenzel-Seifert K, Krautwurst D, Lentzen H, Seifert R: Concavalin A and mistletoe lectin I differentially activate cation entry and exocytosis in human neutrophils: Lectins may activate multiple subtypes of cation channels. J Leukoc Biol 1996;60:345-355.
53. Baxevanis CN, Voutsas LF, Soler MH, Gritzapis AD, Tsitsilonis OE, Stoeva S, Voelter W, Arsenis P, Papamichail M: Mistletoe lectin I-induced effects on human cytotoxic lymphocytes. Synergism with IL-2 in the induction of enhanced LAK cytotoxicity. Immunopharmacol Immunotoxicol 1998;20:355-372.
54. Vehmeyer K, Hajto T, Hostanska K, Könermann S, Lösert H, Saller R, Wörmann B: Lectin-induced increase in clonogenic growth of hematopoietic progenitor cells. Eur J Hematol 1998;60:16-20.
55. Beuth J, Ko HL, Tunggal L, Buss G, Jeljaszewicz J, Steuer MK, Pulverer G: Immunaktive Wirkung von Mistellektin l in Abhängigkeit von der Dosierung. Arzneimittelforschung 1994; 44:1255-1258.
56. Beuth J, Stoffel B, Ko HL, Buss G, Tunggal L, Pulverer G: Immunaktive Wirkung verschiedener Mistellektin-1 Dosierungen in Mammakarzinompatientinnen. Arzneimittelforschung 1995; 45:505-507.
57. Hajto T, Hostanska K, Herrmann R: Immunomodulatory potency of mistletoe lectins in cancer patients. Results of a dose finding study. Allergy 1993;48(suppl):548.
58. Hajto T, Hostanska K, Gabius H-J: Zytokine als Lektin-induzierte Mediatoren in der Misteltherapie. Therapeutikon 1990;4:136-145.
59. Ziska P, Gelbin M, Franz H: Interaction of mistletoe lectins ML-I, ML-II, and ML-III with carbohydrates; in van Driessche E, Franz H, Beeckmans R, Pfüller U, Kallikorm A, Bog-Hansen TC (eds): Lectins: Biology Biochemistry, Clinical Biochemistry. Berlin, Walter de Gruyter, 1993, vol 8, pp 10-13.
60. Beuth J, Ko HL, Gabius HJ, Burrichter H, Dette K, Pulverer G: Behaviour of lymphocyte subsets and expression of activation markers in response to immunotherapy with galactoside-specific lectin from mistletoe in breast cancer patients. Clin Invest 1992;70:658-661.
61. Beuth J, Gabius HJ, Steuer MK, Geisel J, Steuer M, Ko HL, Pulverer G: Effect of mistletoe lectin therapy on serum level of defined serum proteins (acute phase proteins) in tumor patients. Med Klin 1993;88:287-290.
62. Beuth J, Ko HL, Tunggal L, Geisel J, Pulverer G: Comparative studies on the immunoactive action of galactoside-specific mistletoe lectin. Pure substance compared to the standardized extract. Arzneimittelforschung 1993;43:166-169.
63. Mayer H, Steppkes R, Roth R, Richter C-P: Mistelextrakte zur Immunmodulation bei Tumorpatienten. Pharm Ztg 1996;141:11-23.
64. Hajto T, Hostanska K, Fischer J, Lentzen H: Investigations of cellular parameters to establish the response of a biomodulator: Galactoside-specific lectin from Viscum album plant extract. Phytomedicine 1996;3:129-137.
65. Heiny BM, Beuth J: Mistletoe extract standardized for the galactoside-specific lectin (ML-1) induces beta-endorphin release and immunopotentiation in breast cancer patients. Anticancer Res 1994;14:1339-1342.
66. Heiny BM, Albrecht V, Beuth J: Correlation of immune cell activities and beta-endorphin release in breast carcinoma patients treated with galactose-specific lectin standardized mistletoe extract. Anticancer Res 1998;18:583-586.
67. Beuth J, Ko HL, Gabius H-J, Pulverer G: Influence of treatment with the immunomodulatory effective dose of the β-galactoside-specific lectin from mistletoe on tumor colonization in BALB/c-mice for two experimental model systems. In Vivo 1991;5:29-32.
68. Hajto T, Hostanska K, Steinberg F, Gabius H-J: Galactoside-specific lectin from clinically applied mistletoe extract reduces tumor growth by augmentation of host defense system. Blut 1990; 61:164.
69. Kunze E, Schulz H, Ahrens H, Gabius HJ: Lack of an antitumoral effect of immunomodulatory galactoside-specific mistletoe lectin on N-methyl-N-nitrosurea-induced urinary bladder carcinogenesis in rats. Exp Toxicol Pathol 1997;49:167-180.
70. Kunze E, Schulz H, Gabius HJ: Inability of galactoside-specific mistletoe lectin to inhibit N-methyl-N-nitrosurea-induced tumor development in the urinary bladder of rats and to mediate a local cellular immune response after long-term administration. J Cancer Res Clin Oncol 1998;124:73-87.
71. Kuttan G, Menon LG, Antony S, Kuttan R: Anti-carcinogenic and antimetastatic activity of Iscador. Anticancer Drugs 1997; 8(suppl 1):15-16.
72. Antony S, Kuttan R, Kuttan G: Effect of Viscum album in the inhibition of lung metastasis in mice induced by B16F10 melanoma cells. J Exp Clin Cancer Res 1997;16:159-162.
73. Zarkovic N, Zarkovic K, Grainca S, Kissel D, Jurin M: The Viscum album preparation Isorel inhibits the growth of melanoma B16F10 by influencing the tumour-host relationship. Anticancer Drugs 1997;8(suppl 1):17-22.
74. Drees M, Berger DP, Dengler WA, Fiebig GH: Direct cytotoxic effects of preparations used as unconventional methods in cancer therapy in human tumor xenografts in the clonogenic assay and in nude mice; in Arnold W, Köpf-Maier P, Micheel B (eds): Immunodeficient Animals: Models for Cancer Research. Basel, Karger, 1996, vol 51, pp 115-122.
75. Weber K, Mengs U, Schwarz T, Hajto T, Hostanska K, Allen TR, Weyhenmeyer R, Lentzen H: Effects of a standardized mistletoe preparation on metastatic B16 melanoma colonization in murine lungs. Arzneimittelforschung 1998;48:497-502.
76. Hajto T, Hostanska K, Fornalski M, Kirsch A: Antitumorale Aktivität des immunmodulatorisch wirkenden Beta-galaktosidspezifischen Mistellektins bei der klinischen Anwendung von Mistelextrakten (Iscador). Dtsch Z Onkol 1991;23:1-6.
77. Friess H, Beger HG, Kunz J, Funk N, Schilling M, Buchler MW: Treatment of advanced pancreatic cancer with mistletoe: Result of a pilot trial. Anticancer Res 1996;16:915-920.
78. Heiny BM, Beuth J: Das Lektin der Mistel als Immunmodulator: Effektorwirkung auf β-Endorphin- und Zytokinfreisetzung bei Mammakarzinompatientinnen. Dtsch Z Onkol 1994;26:103-108.
79. Kuttan G, Kuttan R: Reduction of leukopenia in mice by 'viscum album' administration during radiation and chemotherapy. Tumori 1993;79:74-76.
80. Lenartz D, Stoffel B, Menzel J, Beuth J: Immunoprotective activity of the galactoside-specific lectin from mistletoe after tumor destructive therapy in glioma patients. Anticancer Res 1996;16:3799-3802.
81. Beuth J, Ko HL, Tunggal L, Buss G, Jeljaszewicz J, Steuer MK, Pulverer G: Immunoprotective activity of the galactoside-specific mistletoe lectin in cortisone-treated BALB/c-mice. In Vivo 1994;8:989-992.
82. Weber K, Mengs U, Schwarz T, Becker H, Lentzen H: Stimulation of neutropoiesis by a special standardized mistletoe preparation after cyclophosphamide chemotherapy in mice. Arzneimittelforschung 1996;46:1174-1178.
83. Stoffel B, Beuth J, Pulverer G: Effect of immunomodulation with galactoside-specific mistletoe lectin on experimental listerosis. Zentralbl Bakteriol 1996;284:439-442.
84. Kovacs E, Hajto T, Hostanska K: Improvement of DNA repair in lymphocytes of breast cancer patients treated with Viscum album extract (Iscador). Eur J Cancer 1991;27:1672-1676.